Delivery Order SPE2DB20D1100-SPE2DB25FC6K0
Award Date 6/2/25
Potential Completion Date 6/3/25
Potential Value $8.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $7,904.97 to AmerisourceBergen Drug Corp for the supply of Myrbetriq ER 50 mg tablets (90-count packages). This firm fixed-price, non-set-aside contract was awarded on August 25, 2025, with an ultimate completion date of August 26, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Myrbetriq is a prescription medication used to treat overactive bladder, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $5,528.86 to AmerisourceBergen Drug Corp for the supply of Myrbetriq ER 50 mg tablets (90-count supply). This competitively awarded, firm fixed-price delivery order was issued on August 27, 2025, with an ultimate completion date of August 28, 2025. The contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Myrbetriq is a prescription medication used to treat...
- The Defense Logistics Agency awarded a $3,722.97 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Myrbetriq ER 50 mg, a medication used to treat overactive bladder. This non-set-aside, competitively awarded contract utilized firm fixed pricing and is scheduled for completion by August 25, 2025. The order will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $2,746.38 to AmerisourceBergen Drug Corp for 90 tablets of Myrbetriq ER 50 mg, a medication commonly used to treat overactive bladder. The award was made on September 12, 2025, with an ultimate completion date of September 15, 2025, under a firm fixed-price contract type with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $4,013.94 to AmerisourceBergen Drug Corp for 90-count tablets of Myrbetriq ER 50 mg, a medication used to treat overactive bladder. Awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, this firm fixed-price contract utilized competitive procedures with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order valued at $3,490.90 to AmerisourceBergen Drug Corp for 90 tablets of Myrbetriq ER 25 mg, a pharmaceutical product used in the treatment of overactive bladder. This competitively awarded, firm fixed-price contract was executed on August 29, 2025, with an ultimate completion date of September 2, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was...
- The Defense Logistics Agency (DLA) awarded a $35,989.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 90 tablets of Myrbetriq ER 50 mg, a pharmaceutical product for treating overactive bladder. The award was made on June 30, 2025, with an ultimate completion date of July 1, 2025, and performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $6,265.49 to AmerisourceBergen Drug Corp for 90-count tablets of Myrbetriq ER 50 mg, a medication used to treat overactive bladder. This non-competitive, firm fixed-price delivery order was issued on September 19, 2025, with an ultimate completion date of September 22, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a $4,349.10 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units). This is a firm fixed price, non-set-aside contract with a completion date of September 19, 2025, and performance at the vendor's location in Conshohocken, Pennsylvania. Myrbetriq is a prescription medication used to treat overactive bladder, representing the type of pharmaceutical commodity that the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $3,683.89 to AmerisourceBergen Drug Corp for 90-count tablets of Myrbetriq ER 50 mg, a pharmaceutical product used in the treatment of overactive bladder. The contract, awarded September 4, 2025, with an ultimate completion date of September 5, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, fulfilled this order as part of its broader...